Uber COO Andrew Macdonald gave voice to the growing concerns that, despite spending big on AI, companies aren't seeing meaningful returns.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Six months ago, the AI sector was looking pretty bubbly. Companies were plowing hundreds of billions of dollars, much of it ...

Larry Fink, of Blackrock, world's largest money manager, contended there is no AI bubble but rather huge investment ...

The S&P 500 rally is highly concentrated in AI-related stocks, with 85% of gains driven by a handful of hyperscalers. Click ...

At the 2026 Met Gala, the Fashion Is Art dress code inspired interpretations from across history, including Renaissance renderings of the human body, art-movement-traversing nudes, and Grecian dresses ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Prepare to be amazed by the world-famous Gazillion Bubble Show! This mind-blowing show combines the beauty of bubble artistry, the wonders of soapy science, and interactive musical fun for the whole ...